“On the day I gave birth, the Phreesia representative replied, “Unfortunately, since we have deleted your authorization, we no longer have a copy of that authorization on file to provide you.””
Phreesia’s check-in tablet labels its ad-targeting consent form “Required” in bright red letters. The opt-out sits eight paragraphs down. Rosenblat clicked “I decline” at every visit and kept photos, and Phreesia still claimed she had consented, then deleted the proof when she asked for it. Its SEC filing brags that exposed patients are four and a half times more likely to fill the advertised prescription. That number is the product, and the patient is the inventory.